 |
市场调查报告书
商品编码
1935125
兽用原料药市场按类型、动物种类、剂型、治疗用途、给药途径、生产类型、销售管道及地区划分Veterinary API Market, By Type, By Animal Type, By Formulation, By Therapeutic Application, By Route of Administration, By Manufacturing Type, By Sales Channel, By Geography |
||||||
预计到 2026 年，兽用原料药市场规模将达到 99.7 亿美元，到 2033 年将达到 164.3 亿美元，2026 年至 2033 年的复合年增长率为 7.4%。
| 报告内容 | 报告详情 | ||
|---|---|---|---|
| 基准年： | 2025 | 2026年市场规模： | 99.7亿美元 |
| 历史数据时期： | 2020年至2024年 | 预测期： | 2026年至2033年 |
| 预测期（2026-2033年）复合年增长率： | 7.40% | 2033 年的预测值： | 164.3亿美元 |
全球兽用原料药市场是更广泛的医疗保健产业的重要组成部分，涵盖了用于製备兽药的基本化学化合物和生物物质。兽用原料药是用于治疗、预防和控制伴侣动物、家畜和水产养殖物种疾病的药物产品中的关键治疗成分。
由于人们对动物健康的日益关注、宠物饲养率的上升、动物蛋白消费需求的增长以及食品安全和动物福利标准方面严格法规的实施，兽用原料药市场的重要性日益凸显。兽用原料药市场涵盖多种类别，例如抗感染剂、驱虫药、抗发炎药、麻醉剂和激素，每种类别都满足兽医学中特定的治疗需求。
市场动态受多种因素影响，例如通用感染疾病的出现、动物医药研究的进步、为满足全球食品需求而增加的畜牧业、宠物人性化趋势的兴起等等。此外，动物医药研发和核准流程的法律规范在塑造各地区的市场成长模式和竞争格局方面也发挥着至关重要的作用。
市场动态
全球兽用原料药市场成长的主要驱动力是宠物饲养量的快速增长以及伴侣动物医疗保健支出的不断攀升，宠物饲主越来越将动物视为家庭成员，并要求提供高品质的医疗保健服务。全球肉品消费量量的增长和畜牧业生产的扩张促使人们呼吁加强动物健康管理，这反过来又推动了对兽用原料药的需求，以确保动物福利和食品安全标准。
製药生产领域的技术创新，特别是新型动物给药系统和精准医疗方法的开发，正在创造新的成长机会。然而，市场也面临许多製约因素。严格的法规结构要求进行广泛的临床试验和漫长的核准流程，这增加了新动物医药上市时间和研发成本。
假冒仿冒品兽药的存在构成严峻挑战，尤其是在新兴市场，严重影响市场信誉和病人安全。此外，农村和发展中地区兽医短缺限制了市场渗透率和优质兽医服务的可近性。
儘管面临这些挑战，新兴市场仍蕴藏着巨大的发展机会。可支配收入的成长和动物保健意识的提高，正在创造尚未开发的市场潜力。随着全球水产养殖业的持续扩张，用于水产养殖的原料药开发代表着巨大的成长机会。此外，人们对预防性动物保健的日益重视，以及对有机和天然动物产品需求的成长，也为原料药的开发和市场拓展开闢了新的途径。
本次调查的主要特点
- 本报告对全球兽用原料药市场进行了详细分析，以 2025 年为基准年，给出了预测期（2026-2033 年）内的市场规模（十亿美元）和復合年增长率（%）。
- 我们将重点介绍各个细分市场的潜在商机，并说明该市场具有吸引力的投资提案矩阵。
- 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要参与者采取的竞争策略的重要见解。
- 本报告根据以下参数介绍了全球兽用原料药市场主要企业的概况：公司概况、产品系列、主要亮点、财务表现和策略。
- 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 这份全球兽用原料药市场报告的目标受众是该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
- 相关人员可以透过各种用于分析全球兽用原料药市场的策略矩阵轻鬆做出决策。
目录
第一章 研究目标与前提条件
- 调查目的
- 先决条件
- 简称
第二章 市场范围
- 报告概述
- 市场定义和范围
- 执行摘要
第三章 市场动态、监管与趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 法规环境
- 产品上市及核准情况
- PEST分析
- 波特分析
- 市场机会
- 法规环境
- 重大进展
- 产业趋势
4. 2021-2033年全球兽用活性原料药市场（依类型划分）
- 抗感染药物
- 抗发炎药
- 抗寄生虫药物
- 荷尔蒙和类固醇
- 维生素和营养素
- 麻醉剂
- 其他成分（例如，皮肤科原料药、电解质）
5. 2021-2033年全球兽用原料药市场（依动物种类划分）
- 伴侣动物
- 家畜
6. 2021-2033年全球兽用原料药市场（以剂型划分）
- 固态的
- 液体
7. 2021-2033年全球兽用原料药市场（依治疗应用划分）
- 感染疾病控制
- 疼痛和炎症管理
- 寄生虫控制
- 代谢和内分泌紊乱
- 生殖健康
- 营养支持
- 麻醉和镇静
- 其他（例如，皮肤科）
8. 2021-2033年全球兽用原料药市场（依给药途径划分）
- 口服
- 肠外
- 外用
- 黏膜
9. 2021-2033年全球兽用原料药市场（依生产类型划分）
- 契约製造
- 内部生产
10. 2021-2033年全球兽用原料药市场依销售管道
- 在线的
- 离线
11. 2021-2033年全球兽用原料药市场（依地区划分）
- 北美洲
- 我们
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲国家
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 亚太其他地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家
- 非洲
- 南非
- 北非
- 中非
第十二章 竞争格局
- Zoetis Inc
- SUANFARMA SA
- Grupo Indukern SL
- Sequent Scientific Limited
- Ofichem Group
- Alivira Animal Health Limited
- Excel Industries Ltd
- Chempro Pharma Private Limited
- NGL Fine Chem Ltd
- FIS-Fabbrica Italiana Sintetici SpA
- AMGIS Lifescience Ltd
- Huvepharma AD
- Vetpharma Animal Health SL
- Qilu Animal Health Products Co Ltd
- Menadiona
第十三章 分析师建议
- 机会
- 分析师观点
- Coherent Opportunity Map
第十四章 参考文献与调查方法
- 参考
- 调查方法
- 关于本公司
Veterinary API Market is estimated to be valued at USD 9.97 Bn in 2026 and is expected to reach USD 16.43 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9.97 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.40% | 2033 Value Projection: | USD 16.43 Bn |
The global veterinary API market represents a critical segment within the broader animal healthcare industry, encompassing the fundamental chemical compounds and biological substances used in the formulation of veterinary medicines. Veterinary APIs serve as the primary therapeutic components in medications designed to treat, prevent, and manage diseases across companion animals, livestock, and aquaculture species.
This market has gained significant prominence due to the increasing awareness of animal health, rising pet ownership rates, growing demand for animal protein consumption, and the implementation of stringent regulations regarding food safety and animal welfare standards. The veterinary API landscape comprises various categories including anti-infectives, parasiticides, anti-inflammatory agents, anesthetics, and hormones, each addressing specific therapeutic needs within veterinary medicine.
The market dynamics are influenced by factors such as the emergence of zoonotic diseases, advancement in veterinary pharmaceutical research, increasing livestock production to meet global food demand, and the growing trend of pet humanization. Additionally, the regulatory framework governing veterinary drug development and approval processes plays a crucial role in shaping market growth patterns and competitive landscapes across different geographical regions.
Market Dynamics
The global veterinary API market growth is primarily driven by the exponential growth in pet ownership and the increasing expenditure on companion animal healthcare, as pet owners increasingly view their animals as family members requiring premium medical care. The rising global meat consumption and expanding livestock industry necessitate enhanced animal health management, driving demand for veterinary APIs to ensure animal welfare and food safety standards.
Technological advancements in pharmaceutical manufacturing, including the development of novel drug delivery systems and precision medicine approaches for animals, are creating new growth opportunities. However, the market faces significant restraints including stringent regulatory frameworks that require extensive clinical trials and lengthy approval processes, increasing the time-to-market and development costs for new veterinary APIs.
The presence of counterfeit and substandard veterinary medicines poses serious challenges, particularly in emerging markets, affecting market credibility and patient safety. Additionally, the limited number of veterinarians in rural areas and developing regions restricts market penetration and accessibility to quality veterinary care.
Despite these challenges, substantial opportunities exist in the form of emerging markets expansion, where increasing disposable income and growing awareness about animal health are creating untapped potential. The development of APIs for aquaculture applications presents significant growth prospects as fish farming continues to expand globally. Furthermore, the increasing focus on preventive healthcare in animals, coupled with the growing trend of organic and natural veterinary products, opens new avenues for API development and market expansion.
Key Features of the Study
- This report provides in-depth analysis of the global veterinary API market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global veterinary API market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Zoetis Inc, SUANFARMA S.A, Grupo Indukern S.L, Sequent Scientific Limited, Ofichem Group, Alivira Animal Health Limited, Excel Industries Ltd, Chempro Pharma Private Limited, NGL Fine Chem Ltd, FIS - Fabbrica Italiana Sintetici S.p.A, AMGIS Lifescience Ltd, Huvepharma AD, Vetpharma Animal Health S.L, Qilu Animal Health Products Co Ltd, and Menadiona
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global veterinary API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary API market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Anti infectives
- Anti inflammatory Drugs
- Antiparasitic Agents
- Hormones and Steroids
- Vitamins and Nutrients
- Anesthetics
- Others (e.g., Dermatological APIs, Electrolytes)
- Animal Type Insights (Revenue, USD Bn, 2021 - 2033)
- Companion Animals
- Dogs
- Cats
- Others (e.g., rabbits, birds)
- Livestock
- Cattle
- Swine
- Poultry
- Sheep and Goats
- Others (e.g., equine)
- Formulation Insights (Revenue, USD Bn, 2021 - 2033)
- Solid
- Tablets
- Capsules
- Powders
- Semi solid
- Ointments
- Gels
- Liquid
- Injectables
- Oral Solutions/Suspensions
- Therapeutic Application Insights (Revenue, USD Bn, 2021 - 2033)
- Infectious Disease Management
- Pain/Inflammation Management
- Parasitic Control
- Metabolic and Endocrine Disorders
- Reproductive Health
- Nutritional Support
- Anesthesia/Sedation
- Others (e.g., Dermatology)
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Parenteral
- Topical
- Mucosal
- Manufacturing Type Insights (Revenue, USD Bn, 2021 - 2033)
- Contract Manufacturing
- In house Manufacturing
- Sales Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Online
- Offline
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Zoetis Inc
- SUANFARMA S.A
- Grupo Indukern S.L
- Sequent Scientific Limited
- Ofichem Group
- Alivira Animal Health Limited
- Excel Industries Ltd
- Chempro Pharma Private Limited
- NGL Fine Chem Ltd
- FIS - Fabbrica Italiana Sintetici S.p.A
- AMGIS Lifescience Ltd
- Huvepharma AD
- Vetpharma Animal Health S.L
- Qilu Animal Health Products Co Ltd
- Menadiona
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Veterinary API Market, By Type
- Global Veterinary API Market, By Animal Type
- Global Veterinary API Market, By Formulation
- Global Veterinary API Market, By Therapeutic Application
- Global Veterinary API Market, By Route of Administration
- Global Veterinary API Market, By Manufacturing Type
- Global Veterinary API Market, By Sales Channel
- Global Veterinary API Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Veterinary API Market, By Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Anti infectives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anti inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Antiparasitic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hormones and Steroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Vitamins and Nutrients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (e.g., Dermatological APIs, Electrolytes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Veterinary API Market, By Animal Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Companion Animals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Dogs
- Cats
- Others (e.g., rabbits, birds)
- Livestock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cattle
- Swine
- Poultry
- Sheep and Goats
- Others (e.g., equine)
6. Global Veterinary API Market, By Formulation, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Solid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Tablets
- Capsules
- Powders
- Semi solid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ointments
- Gels
- Liquid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Injectables
- Oral Solutions/Suspensions
7. Global Veterinary API Market, By Therapeutic Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Infectious Disease Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pain/Inflammation Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Parasitic Control
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Metabolic and Endocrine Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Reproductive Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Nutritional Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anesthesia/Sedation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (e.g., Dermatology)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Veterinary API Market, By Route of Administration, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Mucosal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Veterinary API Market, By Manufacturing Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Contract Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- In house Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
10. Global Veterinary API Market, By Sales Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
11. Global Veterinary API Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Zoetis Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SUANFARMA S.A
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Grupo Indukern S.L
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sequent Scientific Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ofichem Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alivira Animal Health Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Excel Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Chempro Pharma Private Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NGL Fine Chem Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- FIS - Fabbrica Italiana Sintetici S.p.A
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AMGIS Lifescience Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Huvepharma AD
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vetpharma Animal Health S.L
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qilu Animal Health Products Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Menadiona
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
